C1273380||Mutant Prevention Concentration
C1136255||Topical Antimicrobial Agents
C0033477||Propionibacterium acnes
C1273380||mutant prevention concentration
C1273380||mutant prevention concentration
C1136254||antimicrobial agents
C0004611||bacteria
C1136254||antimicrobial
C0087111||therapies
C1273380||MPCs
C1136255||topical antimicrobial agents
C0033477||Propionibacterium acnes
C0038172||Staphylococcus aureus
C0162627||skin infections
C1273380||MPCs
C0286402||nadifloxacin
C0008947||clindamycin
C0008947||clindamycin
C1273380||mutant prevention concentration
C0033477||P. acnes
C0286402||nadifloxacin
C1273380||mutant prevention concentration
C0038172||S. aureus
C1304747||minimum inhibitory concentrations
C1273380||MPCs
C0008947||clindamycin
C0033477||P. acnes
C0038172||S. aureus
C0286402||Nadifloxacin
C0033477||P. acnes
C0038172||S. aureus
C0033477||P. acnes
C0013203||resistance
C0949665||fluoroquinolones
C0038172||S. aureus
C0008947||clindamycin
C0013203||resistant
C0033477||P. acnes
C0038172||S. aureus